Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Lewis acid catalysis improves Rociletinib yield and purity. Reliable pharmaceutical intermediate supplier offering cost-effective scale-up solutions.
Novel ionic liquid method for SU1498 production ensures high purity and cost efficiency, offering a scalable solution for reliable pharmaceutical intermediate suppliers targeting VEGFR2 inhibitors.
Patent CN101139274B reveals a breakthrough Coenzyme Q10 synthesis using Grubbs catalyst. Discover cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Novel Pd-Cu catalytic method for phenanthrene intermediates ensures high purity and scalable production for global pharmaceutical supply chains.
Patent CN105384710A reveals a novel Ru-Sc synergistic catalytic method for furan intermediates. Achieves high purity and yield with simplified post-processing for scalable supply.
Novel metal-free method for triaryl phosphine intermediates. Reduces cost and complexity. Reliable supplier for pharma and agrochemical manufacturing.
Novel Pd-Cu catalytic method for phenanthrene intermediates. High yield, scalable process, cost-effective supply chain solutions for global pharma.
Advanced Pd-Cu catalytic method for phenanthrene compounds. Delivers high yield and purity for pharmaceutical manufacturing. Reliable supply chain partner.
Patent CN120794988A reveals efficient chiral phosphoric acid catalysis for high-purity indole derivatives, offering significant supply chain and cost advantages.
Novel synthesis of chiral optical pure alkynylamide substituted α,β-diamino acid derivatives via Rh-catalyzed three-component reaction for potent anticancer applications.
Patent CN113444702B reveals high-efficiency OYE1 mutant for Brivaracetam intermediate production, offering superior conversion and ee values for scalable API manufacturing.
Patent CN111170918A details a cost-effective iridium-catalyzed C-H amination route for lactams, offering significant supply chain stability and reduced manufacturing costs for pharma intermediates.
Patent CN112739683B reveals a novel Brivaracetam synthesis using Quinine catalysts. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114075108A details a metal-free visible light method for aldehyde deuteration, offering significant cost reduction and scalability for pharmaceutical intermediate manufacturing.
Patent CN103896816A reveals advanced Ir-catalyzed synthesis for chiral allyl thiocarboxylates. Discover cost-effective manufacturing and reliable supply chain solutions.
Patent CN102781948A details stable P-chiral aminodiphosphine ligands enabling high-ee asymmetric hydrogenation for cost-effective chiral pharmaceutical intermediates manufacturing.
Patent CN111574487B details a novel asymmetric hydrogenation method for producing high-purity chiral dihydroisoflavones, offering significant supply chain and cost advantages.
Patent CN105624214A reveals high-efficiency enzymatic synthesis. Offers supply chain stability and cost reduction in agrochemical intermediate manufacturing without heavy metals.
Patent CN111777520B reveals a safe, high-yield synthesis route for dimethylamino phenyl acetic acid intermediates, offering significant cost and safety advantages.
Patent CN102190592B reveals a novel NHC-catalyzed route for DMF, eliminating salt blockages and ensuring continuous production for reliable supply chains.